Did you know that Amazon Prime was going to rise to $119 a year?

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Financial Accounting, Intermediate Accounting, Managerial Accounting, Video Updates.

According to the Washington Post, Amazon is justifying Prime’s 20 percent price hike, to $119 a year, by saying it is more a valuable service than when the fee last rose four years ago. Questions: 1. How many Amazon customers are Prime members? 2. What did the article (April 27) offer as alternatives or ways… Read more »

From White House to the Big House?

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Fraud Accounting, IFRS, Income Taxes, Intermediate Accounting, International Accounting, Managerial Accounting, Video Updates.

It was only a week ago that President Donald Trump was praising Caterpillar Co. for producing such great bulldozers, as he met with company Chairman Doug Oberhelman at the White House. Less than a week later, officials from the Commerce Department, Internal Revenue Service, Federal Deposit Insurance Corp. and Illinois State Police moved in and… Read more »

No more breakfast!

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Financial Accounting, Income Taxes, Intermediate Accounting, International Accounting, Managerial Accounting.

All-day breakfast is beginning to lose its novelty for McDonald’s Corp. Questions: 1. What happened to last quarter’s domestic same-store sales? 2. In your opinion, what will be McDonald’s next big source of growth? 3. Are the profit potentials the same for McDonald’s globally? Explain. Source: Giammona, C. (2017). McDonald’s All-Day Breakfast Push No Longer… Read more »

Deutsche Bank Shares Drop

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, International Accounting, Managerial Accounting, Video Updates.

Deutsche Bank’s shares hit a record low, but Germany’s largest lender said there is no reason to get the German government’s help in settling claims of $14 billion with the U.S. Justice Department (DoJ). Questions: 1. What is the record low price of shares of Deutsche Bank? 2. What is a summary of the lender’s… Read more »

Corporate Culture Sinks the Firm

Posted by & filed under Accounting Information Systems, Accounting Principles, All Articles, Auditing, Cost Accounting, Financial Accounting, Fraud Accounting, Intermediate Accounting, International Accounting, Managerial Accounting, Video Updates.

The chief executive of Toshiba and two of his predecessors resigned, along with several lesser executives, over accusations that they drove the company to overstate its earnings by $1.2 billion over the last seven years. The figure is equal to about a third of the pretax profits that Toshiba reported during that period. Questions: 1…. Read more »

A Big Bet!

Posted by & filed under Accounting Information Systems, Accounting Principles, Auditing, Cost Accounting, Financial Accounting, Intermediate Accounting, Managerial Accounting.

Pfizer is making a $15.2 billion bet on the drug industry’s new, more elite class of generics, which are costly, complex copies of already expensive biotech drugs. Questions: 1. What are biosimilars? 2. Why are there questions about the durability of the market for these specialty drugs? 3. What is the dollar estimate of the… Read more »

Biotechnology Firm, Amgen, Acquires Anti-cancer Drugs

Posted by & filed under Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Financial Accounting, Financial Reporting and Analysis, Financial Statement Analysis, Fraud Accounting, IFRS, Intermediate Accounting, International Accounting, Managerial Accounting.

Although Amgen is the world’s largest biotechnology company, they have not been in the anti-cancer drug market until now. Amgen, like other drug makers, is trying to refresh aging product lines through the acquisition. Questions: 1. What is the ranking of this takeover of biotechnology firms, in terms of historic purchases? What are examples of… Read more »